STOCK TITAN

Microvision Inc (MVIS) Financials

MVIS
Trailing 12 months to June 30, 2026
Revenue $2.9M +11.1% YoY
Net Income -$114.2M -27.4% YoY
EPS (Diluted) -$0.35 FY2025 annual
Free Cash Flow -$68.3M -21.1% YoY
Market Cap $45.0M as of Oct 6, 2026
Price / Sales 15.7x on $2.9M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 2.2x on $20.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MVIS SEC filings page.

Microvision Inc (MVIS) reported $2.9M in revenue over the twelve months to Jun 30, 2026, up 11.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MVIS FY2025

MicroVision remains a development-stage business: operating costs vastly exceed sales, while external financing supplies cash as operations remain negative.

FY2025’s net loss was $95.0M, but operating cash flow was -$58.7M; the gap indicates non-cash charges and working-capital effects materially softened the cash impact. Because free cash flow was -$59.4M against operating cash flow, capital spending added little to the cash burden, so the central need is funding ongoing operations rather than heavy reinvestment.

Development spending dominates the current model: R&D was $31.7M while revenue was $1.2M, making commercialization scale—not incremental cost control—the missing economic bridge. The operating loss was $82.8M, showing that the cost base remains largely disconnected from current sales volume.

Operations are financed externally: financing cash flow provided $60.9M while shares outstanding reached 306.6M, showing external capital—not operations—funded cash needs. The reported liquidity measure equaled 15.3 months of FY2025 operating outflow and the current ratio was 2.7x, describing year-end liquidity without implying operating self-sufficiency.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 44 / 100
Financial Health Score 44/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Microvision Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
39

Microvision Inc held $74.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $58.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Microvision Inc scores 39/100 among other emerging companies.

Dilution
30

Microvision Inc had 307M shares outstanding at the end of fiscal year 2025, against 245M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Microvision Inc scores 30/100 among other emerging companies.

R&D Intensity
69

Microvision Inc spent $31.7M on research and development in fiscal year 2025, which was 37.7% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Microvision Inc scores 69/100 among other emerging companies.

Revenue Progress
3

Microvision Inc reported revenue of $1.2M in fiscal year 2025, against $4.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Microvision Inc scores 3/100 among other emerging companies.

Burn Trend
52

Microvision Inc's operations used $58.7M of cash in fiscal year 2025, against $68.5M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Microvision Inc scores 52/100 among other emerging companies.

Balance Sheet
70

Microvision Inc's cash, cash equivalents and investments came to $74.9M at the end of fiscal year 2025, against $47.6M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Microvision Inc scores 70/100 among other emerging companies.

Altman Z-Score Distress
-14.48

Microvision Inc scores -14.48, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($45.0M) relative to total liabilities ($47.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

Microvision Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Microvision Inc reported a net loss of $95.0M while operations used $58.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Microvision Inc reported an operating loss of $82.8M against $7.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.5M
YoY+850.3%
QoQ+57.5%
5Y CAGR+14.6%
10Y CAGR-9.9%

Microvision Inc generated $1.5M in revenue in Q2 2026. This represents an increase of 850.3% from the same quarter a year earlier. Against the prior quarter it is up 57.5%.

EBITDA
-$22.5M
YoY-60.2%
QoQ-6.5%

Microvision Inc's EBITDA was -$22.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 60.2% from the same quarter a year earlier. Against the prior quarter it is down 6.5%.

Net Income
-$36.9M
YoY-159.6%
QoQ-46.1%

Microvision Inc reported -$36.9M in net income in Q2 2026. This represents a decrease of 159.6% from the same quarter a year earlier. Against the prior quarter it is down 46.1%.

EPS (Diluted)
-$1.66
YoY-97.6%

Microvision Inc earned -$1.66 per diluted share (EPS) in Q2 2026. This represents a decrease of 97.6% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow
-$19.4M
YoY-50.3%
QoQ-17.3%

Microvision Inc recorded an outflow of $19.4M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 50.3% from the same quarter a year earlier. Against the prior quarter it is down 17.3%.

Cash & Debt
$27.2M
YoY-63.3%
QoQ-41.0%
5Y CAGR-27.4%
10Y CAGR+14.2%

Microvision Inc held $27.2M in cash against $24.6M in long-term debt as of Q2 2026.

Shares Outstanding
24M
YoY-92.1%
5Y CAGR-32.0%
10Y CAGR-7.5%

Microvision Inc had 24M shares outstanding in Q2 2026. This represents a decrease of 92.1% from the same quarter a year earlier.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
43.6%
QoQ+4.8pp

Microvision Inc's gross margin was 43.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. Against the prior quarter it is up 4.8 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity
-179.2%
YoY-160.7pp
QoQ-115.2pp
5Y change-167.6pp

Microvision Inc's ROE was -179.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 160.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 115.2 percentage points.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$15.7M
YoY+105.0%
QoQ+8.7%

Microvision Inc invested $15.7M in research and development in Q2 2026. This represents an increase of 105.0% from the same quarter a year earlier. Against the prior quarter it is up 8.7%.

Capital Expenditures
$305K
YoY+46.6%
QoQ+113.3%
5Y CAGR-25.4%

Microvision Inc invested $305K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 46.6% from the same quarter a year earlier. Against the prior quarter it is up 113.3%.

Share Buybacks

Not reported for Q2 2026.

MVIS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MVIS quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$1.5M+850.3%$935K+58.7%$223K-86.5%$241K+26.8%$155K-91.8%$589K-38.4%$1.6M-67.7%$190K-81.9%
Cost of Revenue$831K+16.1%$572K+4.0%$16.3M+296.6%$957K+64.2%$716K-53.9%$550K-56.9%$4.1M+356.3%$583K-6.7%
Gross Profit$642K+214.4%$363K+830.8%-$16.1M-553.0%-$716K-82.2%-$561K-262.1%$39K+112.1%-$2.5M-158.7%-$393K-193.1%
R&D Expenses$15.7M+105.0%$14.4M+95.1%$8.7M-0.9%$8.0M-8.7%$7.7M-46.1%$7.4M-57.2%$8.8M-39.9%$8.7M-43.9%
SG&A Expenses$9.2M+43.1%$9.5M+42.5%$3.2M-46.2%$4.0M-39.0%$6.4M-16.9%$6.7M-26.5%$5.9M-37.8%$6.6M-24.5%
Operating Income-$24.2M-65.2%-$23.5M-67.3%-$41.4M-124.2%-$12.7M+19.0%-$14.7M+40.5%-$14.0M+47.4%-$18.5M+7.1%-$15.7M+34.3%
EBITDA-$22.5M-60.2%-$21.1M-67.2%-$38.2M-144.1%-$12.1M+17.0%-$14.1M+40.0%-$12.6M+49.3%-$15.7M+9.8%-$14.6M+34.2%
Interest Expense$5.5M+152.5%$2.8M-61.8%-$4.4M-199.1%$2.2M+10361.9%$2.2M+16592.3%$7.3M+40594.4%$4.4M$21K
Income Tax$181K+94.6%$182K+149.3%-$422K-621.0%$172K+59.3%$93K+10.7%$73K-68.8%$81K-82.9%$108K-48.8%
Net Income-$36.9M-159.6%-$25.3M+12.1%-$37.8M-21.2%-$14.2M+8.4%-$14.2M+40.5%-$28.8M-9.4%-$31.2M-57.9%-$15.5M+33.9%
EPS (Basic)-$1.66-97.6%-$0.08+33.3%-$0.13+7.1%-$0.05+28.6%-$0.84-663.6%-$0.12+7.7%-$0.14-40.0%-$0.07+41.7%
EPS (Diluted)-$1.66-97.6%-$0.08+33.3%-$0.13+7.1%-$0.05+28.6%-$0.84-$0.12+7.7%-$0.14-40.0%-$0.07+41.7%
Diluted Shares (Avg)22M+31.3%309M+30.8%N/A295M+38.7%17M236M+19.9%N/A213M+13.1%

MVIS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MVIS quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$88.6M-37.0%$110.2M-5.6%$103.1M-14.9%$150.8M+70.9%$140.6M+36.0%$116.7M-6.0%$121.2M-6.5%$88.3M-35.1%
Current Assets$34.3M-66.8%$54.2M-31.4%$81.1M-1.6%$115.0M+116.7%$103.2M+55.0%$79.0M-4.0%$82.5M-4.9%$53.0M-42.0%
Cash & Equivalents$27.2M-63.3%$46.1M-11.2%$32.4M-40.6%$72.8M+340.8%$74.1M+177.0%$51.9M+17.2%$54.5M+20.6%$16.5M-66.5%
Short-Term Investments$0-100.0%$0-100.0%$42.5M+110.4%$26.7M0.0%$17.3M-42.1%$17.1M-40.6%$20.2M-29.4%$26.7M-6.9%
Inventory$3.7M-40.3%$4.0M+59.0%$745K-67.5%$8.1M+81.3%$6.1M+45.8%$2.5M-32.2%$2.3M-40.8%$4.5M+24.1%
Accounts Receivable$915K+779.8%$732K+190.5%$47K-94.9%$40K-82.8%$104K-94.7%$252K-77.5%$926K-2.4%$232K-68.6%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$3.7M$3.7MN/AN/AN/AN/AN/AN/A
Total Liabilities$68.0M+7.0%$70.7M+11.2%$47.6M-34.3%$60.1M+168.2%$63.5M+157.1%$63.5M+109.2%$72.4M+114.0%$22.4M-40.5%
Current Liabilities$50.4M+17.7%$51.8M+23.7%$30.1M-34.4%$39.9M+276.0%$42.8M+238.5%$41.9M+135.8%$46.0M+124.1%$10.6M-55.9%
Non-Current Liabilities$17.6M-15.1%$18.9M-12.9%$17.4M-34.1%$20.2M+71.3%$20.7M+71.6%$21.7M+71.7%$26.4M+98.4%$11.8M-13.4%
Long-Term Debt$24.6M-23.9%$32.1M+6.8%$19.2M-41.8%$29.0M$32.3M$30.1M$33.0MN/A
Total Equity$20.6M-73.3%$39.5M-25.7%$55.5M+13.9%$90.7M+37.8%$77.1M-2.0%$53.2M-43.3%$48.8M-49.1%$65.9M-33.0%
Retained Earnings-$1.0B-12.6%-$982.6M-10.3%-$957.3M-11.0%-$919.5M-10.6%-$905.3M-11.0%-$891.1M-12.6%-$862.3M-12.7%-$831.1M-11.5%

MVIS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MVIS quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$19.1M-50.4%-$16.4M-16.6%-$15.4M-2.3%-$16.5M-17.0%-$12.7M+31.7%-$14.1M+32.1%-$15.1M+9.2%-$14.1M+30.9%
Depreciation & Amortization$1.7M+182.6%$2.4M+68.2%$1.5M-11.8%$603K-45.2%$603K-49.8%$1.4M-21.8%$1.7M+6.2%$1.1M-35.5%
Stock-Based CompensationN/A$983K-48.8%N/A-$1.6M-166.1%$1.9M-42.4%$1.9M-48.7%N/A$2.4M-48.3%
Capital Expenditures$305K+46.6%$143K+44.4%$244K+136.9%$128K+1322.2%$208K+25.3%$99K-13.2%$103K+123.9%-$9K-98.2%
Free Cash Flow-$19.4M-50.3%-$16.6M-16.8%-$15.6M-3.2%-$16.6M-17.8%-$12.9M+31.2%-$14.2M+32.0%-$15.2M+8.8%-$14.1M+32.5%
Investing Cash Flow-$305K+5.0%$9.2M+198.0%-$18.0M-377.2%-$9.4M-362.2%-$321K+92.2%$3.1M+194.1%$6.5M+1387.9%$3.6M+32.5%
Financing Cash Flow$345K-99.0%$21.0M+156.4%-$6.9M-114.7%$24.5M+153068.8%$35.1M+580.7%$8.2M-61.0%$46.7M+300.3%-$16K-100.3%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MVIS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MVIS quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin43.6%38.8%+32.2pp-7220.6%-297.1%-361.9%6.6%+40.2pp-149.4%-206.8%
Operating Margin-1643.6%-2512.7%-18570.0%-5278.4%-9455.5%-2383.7%-1119.5%-8266.3%
Net Margin-2508.0%-2705.2%-16930.9%-5899.2%-9180.0%-4886.1%-1888.2%-8166.8%
Return on Equity-179.2%-160.7pp-64.0%-9.9pp-68.0%-4.1pp-15.7%+7.9pp-18.4%+11.9pp-54.1%-26.0pp-63.9%-43.3pp-23.6%+0.3pp
Return on Assets-41.7%-31.6pp-22.9%+1.7pp-36.6%-10.9pp-9.4%+8.2pp-10.1%+13.0pp-24.6%-3.5pp-25.7%-10.5pp-17.6%-0.3pp
Current Ratio0.68-1.7x1.05-0.8x2.69+0.9x2.88-2.1x2.41-2.9x1.89-2.7x1.79-2.4x5.00+1.2x
Debt-to-Equity1.19+0.8x0.81+0.2x0.35-0.3x0.320.0x0.42+0.1x0.57+0.2x0.68+0.3x0.340.0x
Asset Turnover0.020.0x0.010.0x0.000.0x0.000.0x0.000.0x0.010.0x0.010.0x0.000.0x
FCF Margin-1320.4%-1773.9%-7017.5%-6894.6%-8346.5%-2410.4%-918.7%-7421.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Microvision Inc MVIS FY2025 $1.2M -$95.0M N/A $45.0M 44/100
Mesa Laboratories Inc MLAB FY2026 $249.1M $6.7M 2.7% $741.7M 45/100
Vishay Precision Group, Inc. VPG FY2025 $307.2M $5.3M 1.7% $1.1B 58/100
Ituran Location and Control Ltd. ITRN FY2025 $359.0M $58.0M 16.2% $1.0B 74/100

Frequently Asked Questions

What is Microvision Inc's annual revenue?

Microvision Inc (MVIS) reported $1.2M in total revenue for fiscal year 2025. This represents a -74.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Microvision Inc's revenue growing?

Microvision Inc (MVIS) revenue declined by 74.3% year-over-year, from $4.7M to $1.2M in fiscal year 2025.

Is Microvision Inc profitable?

No, Microvision Inc (MVIS) reported a net income of -$95.0M in fiscal year 2025.

Microvision Inc (MVIS) reported diluted earnings per share of -$0.35 for fiscal year 2025. This represents a 23.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Microvision Inc (MVIS) had EBITDA of -$77.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Microvision Inc (MVIS) had $32.4M in cash and equivalents against $19.2M in long-term debt.

Microvision Inc (MVIS) has a return on equity of -171.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Microvision Inc (MVIS) recorded an outflow of $59.4M in free cash flow during fiscal year 2025. This represents a 13.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Microvision Inc (MVIS) recorded an outflow of $58.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Microvision Inc (MVIS) had $103.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Microvision Inc (MVIS) invested $679K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Microvision Inc (MVIS) invested $31.7M in research and development during fiscal year 2025.

Microvision Inc (MVIS) had 307M shares outstanding as of fiscal year 2025.

Microvision Inc (MVIS) had a current ratio of 2.69 as of fiscal year 2025, which is generally considered healthy.

Microvision Inc (MVIS) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Microvision Inc (MVIS) had a return on assets of -92.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Microvision Inc (MVIS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $45.0M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Microvision Inc (MVIS) trades at 15.7x sales, its market capitalization divided by revenue of $2.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $45.0M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Microvision Inc (MVIS) held $74.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $58.7M over that year. Dividing the one by the other, the reported balance equals about 15 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Microvision Inc (MVIS) has an Altman Z-Score of -14.48, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Microvision Inc (MVIS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Microvision Inc (MVIS) reported a net loss of $95.0M while operations used $58.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Microvision Inc (MVIS) reported an operating loss of $82.8M against $7.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Microvision Inc (MVIS) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top